Jazz Pharmaceuticals (JAZZ)
(Delayed Data from NSDQ)
$110.76 USD
-0.53 (-0.48%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $110.81 +0.05 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $5.49 | 0.14% |
Earnings Summary
For their last quarter, Jazz Pharmaceuticals (JAZZ) reported earnings of $5.30 per share, beating the Zacks Consensus Estimate of $4.68 per share. This reflects a positive earnings surprise of 13.25%. Look out for JAZZ's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $5.49 per share, reflecting a year-over-year increase of 13.43%.
Earnings History
Price & Consensus
Zacks News for JAZZ
FDA Accepts AXSM's NDA Resubmission for Migraine Drug, Stock Up
JAZZ: What are Zacks experts saying now?
Zacks Private Portfolio Services